Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

149
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
149
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

176
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
176
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

1.4K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

113
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
113
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

114
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
114
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

228
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
228

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Atrial Fibrillation in Patients with Embolic Stroke of Unknown Etiology and Implantable Loop Recorders-Further Insights of the TRACK AF Study on the Role of ECG and Echocardiography.

Journal of clinical medicine·2023
Same author

Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.

International journal of cardiology·2023
Same author

Very Long-Term Follow-Up in Cardiac Resynchronization Therapy: Wider Paced QRS Equals Worse Prognosis.

Journal of personalized medicine·2021
Same author

Quantifying Left Atrial Size in the Context of Atrial Fibrillation Ablation: Which Echocardiographic Method Correlates to Outcome of Pulmonary Venous Isolation?

Journal of personalized medicine·2021
Same author

Predicting inappropriate S-ICD® episodes by simple 12-lead surface ECG parameters.

Journal of electrocardiology·2021
Same author

Prospective blinded evaluation of smartphone-based ECG for differentiation of supraventricular tachycardia from inappropriate sinus tachycardia.

Clinical research in cardiology : official journal of the German Cardiac Society·2021

Related Experiment Video

Updated: Nov 4, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.4K

Pregnancy in arrhythmogenic cardiomyopathy.

Thomas Wichter1, Peter Milberg, Henry D Wichter

  • 1Klinik für Innere Medizin / Kardiologie, Niels-Stensen-Kliniken, Marienhospital Osnabrück, Herzzentrum Osnabrück/Bad Rothenfelde, Bischofsstr. 1, 49074, Osnabrück, Germany. thomas.wichter@niels-stensen-kliniken.de.

Herzschrittmachertherapie & Elektrophysiologie
|May 25, 2021
PubMed
Summary

Pregnancy in women with arrhythmogenic cardiomyopathy (AC) is generally well-tolerated and uneventful. Most patients experience benign pregnancies without increased risk of heart failure, arrhythmias, or obstetric complications.

Keywords:
ARVCGenetic counselingMaternal outcomesRight ventricleVentricular tachycardia

More Related Videos

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

978
Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

10.9K

Related Experiment Videos

Last Updated: Nov 4, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.4K
Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

978
Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

10.9K

Area of Science:

  • Cardiology
  • Genetics
  • Reproductive Medicine

Background:

  • Arrhythmogenic cardiomyopathy (AC) is a genetic heart muscle disease causing ventricular arrhythmias, heart failure, and sudden cardiac death.
  • Pregnancy presents physiological challenges, including volume overload and myocardial stretch, potentially exacerbating AC.
  • AC's genetic basis and link to exercise suggest pregnancy could be a risk factor.

Purpose of the Study:

  • To evaluate the safety and outcomes of pregnancy in women with arrhythmogenic cardiomyopathy.
  • To determine if pregnancy accelerates AC progression or increases adverse cardiovascular events.

Main Methods:

  • Review of existing clinical data and evidence regarding pregnancy in AC patients.
  • Analysis of reported cardiovascular events, heart failure progression, and obstetric complications.

Main Results:

  • Most pregnancies in AC patients are well-tolerated with uneventful courses.
  • Adverse pregnancy-related symptoms (arrhythmias, syncope, heart failure) and mortality are uncommon.
  • Obstetric complications and AC progression are not significantly increased compared to non-pregnant AC cohorts.

Conclusions:

  • Pregnancy is generally safe for women with arrhythmogenic cardiomyopathy.
  • No medical contraindication exists for pregnancy in AC patients with stable baseline conditions.
  • Genetic counseling and multidisciplinary expert consultation are recommended for affected individuals planning pregnancy.